RESUMEN
Fetal growth restriction (FGR) greatly increases the risk of perinatal morbidity and mortality and is associated with increased uterine artery resistance and levels of oxidative stress. There are currently no available treatments for this condition. The hypothesis that the antioxidant 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl (Tempol) would improve uterine artery function and rescue fetal growth was tested in a mouse model of FGR, using the endothelial nitric oxide synthase knockout mouse (Nos3(-/-)). Pregnant Nos3(-/-) and control C57BL/6J mice were treated with the superoxide dismutase-mimetic Tempol (1 mmol/L) or vehicle from Gestational Day 12.5 to 18.5. Tempol treatment significantly increased pup weight (P < 0.05) and crown-rump length (P < 0.01) in C57BL/6J and Nos3(-/-) mice. Uterine artery resistance was increased in Nos3(-/-) mice (P < 0.05); Tempol significantly increased end diastolic velocity in Nos3(-/-) mice (P < 0.05). Superoxide production in uterine arteries did not differ between C57BL/6J and Nos3(-/-) mice but was significantly increased in placentas from Nos3(-/-) mice (P < 0.05). This was not reduced by Tempol treatment. Placental System A activity was reduced in Nos3(-/-) mice (P < 0.01); this was not improved by treatment with Tempol. Treatment of Nos3(-/-) mice with Tempol, however, was associated with reduced vascular density in the placental bed (P < 0.05). This study demonstrated that treatment with the antioxidant Tempol is able to improve fetal growth in a mouse model of FGR. This was associated with an increase in uterine artery blood flow velocity but not an improvement in uterine artery function or placental System A activity.
Asunto(s)
Antioxidantes/farmacología , Óxidos N-Cíclicos/farmacología , Retardo del Crecimiento Fetal/tratamiento farmacológico , Sistema de Transporte de Aminoácidos A/metabolismo , Animales , Materiales Biomiméticos/farmacología , Velocidad del Flujo Sanguíneo/efectos de los fármacos , Modelos Animales de Enfermedad , Femenino , Desarrollo Fetal/efectos de los fármacos , Desarrollo Fetal/fisiología , Retardo del Crecimiento Fetal/patología , Retardo del Crecimiento Fetal/fisiopatología , Humanos , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Óxido Nítrico Sintasa de Tipo III/deficiencia , Óxido Nítrico Sintasa de Tipo III/genética , Estrés Oxidativo/efectos de los fármacos , Placenta/irrigación sanguínea , Placenta/efectos de los fármacos , Placenta/patología , Placenta/fisiopatología , Embarazo , Marcadores de Spin , Superóxido Dismutasa/metabolismo , Arteria Uterina/efectos de los fármacos , Arteria Uterina/fisiopatologíaRESUMEN
Fetal growth restriction (FGR) is the inability of a fetus to reach its genetically predetermined growth potential. In the absence of a genetic anomaly or maternal undernutrition, FGR is attributable to "placental insufficiency": inappropriate maternal/fetal blood flow, reduced nutrient transport or morphological abnormalities of the placenta (e.g., altered barrier thickness). It is not known whether these diverse factors act singly, or in combination, having additive effects that may lead to greater FGR severity. We suggest that multiplicity of such dysfunction might underlie the diverse FGR phenotypes seen in humans. Pregnant endothelial nitric oxide synthase knockout (eNOS(-/-)) dams exhibit dysregulated vascular adaptations to pregnancy, and eNOS(-/-) fetuses of such dams display FGR. We investigated the hypothesis that both altered vascular function and placental nutrient transport contribute to the FGR phenotype. eNOS(-/-) dams were hypertensive prior to and during pregnancy and at embryonic day (E) 18.5 were proteinuric. Isolated uterine artery constriction was significantly increased, and endothelium-dependent relaxation significantly reduced, compared with wild-type (WT) mice. eNOS(-/-) fetal weight and abdominal circumference were significantly reduced compared with WT. Unidirectional maternofetal (14)C-methylaminoisobutyric acid (MeAIB) clearance and sodium-dependent (14)C-MeAIB uptake into mouse placental vesicles were both significantly lower in eNOS(-/-) fetuses, indicating diminished placental nutrient transport. eNOS(-/-) mouse placentas demonstrated increased hypoxia at E17.5, with elevated superoxide compared with WT. We propose that aberrant uterine artery reactivity in eNOS(-/-) mice promotes placental hypoxia with free radical formation, reducing placental nutrient transport capacity and fetal growth. We further postulate that this mouse model demonstrates "uteroplacental hypoxia," providing a new framework for understanding the etiology of FGR in human pregnancy.
Asunto(s)
Retardo del Crecimiento Fetal/fisiopatología , Modelos Animales , Óxido Nítrico Sintasa de Tipo III/deficiencia , Fenotipo , Placenta/fisiopatología , Arteria Uterina/fisiopatología , Sistema de Transporte de Aminoácidos A/metabolismo , Animales , Transporte Biológico/fisiología , Presión Sanguínea/fisiología , Femenino , Retardo del Crecimiento Fetal/metabolismo , Peso Fetal/fisiología , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Óxido Nítrico Sintasa de Tipo III/genética , Placenta/metabolismo , Embarazo , Proteinuria/metabolismo , Proteinuria/fisiopatología , Superóxidos/metabolismoRESUMEN
Psychological stress is a risk factor for cardiovascular disease including atherosclerosis, but the mechanisms are unknown. The vascular lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is involved in vascular pathology and early atherogenesis. We hypothesized that LOX-1 is up-regulated by psychological stress via the formation of oxygen-derived free radicals, and that treatment with EUK-8 (a superoxide dismutase and catalase mimetic) prevents production of oxygen-derived free radicals and leads to reduced expression of LOX-1 in the vascular wall. As a model for psychological stress, we exposed male apolipoprotein E-deficient mice to repeated restraint stress by placement in a conical tube for 2 h per day for 14 consecutive days. Stressed and control mice were treated with EUK-8 (n = 4-5) or vehicle (n = 4-5). Reactive oxygen species and peroxynitrite levels, as detected by oxidative fluorescence microscopy, were increased in the aortic root of mice exposed to stress compared to those of controls by 212 +/- 22% (mean +/- SEM; p < 0.001) and 110 +/- 6% (p < 0.001), respectively. LOX-1, as detected by immunohistochemistry, was increased by 443 +/- 63% in stressed mice compared to control mice (p < 0.001). EUK-8 reduced reactive oxygen species, peroxynitrite, and LOX-1 levels in stressed mice compared to vehicle-treated stressed mice. To conclude, LOX-1 induced by reactive oxygen species and/or peroxynitrite could be one mechanism by which stress promotes cardiovascular disease.
Asunto(s)
Aorta Torácica/metabolismo , Apolipoproteínas E/deficiencia , Receptores Depuradores de Clase E/biosíntesis , Receptores Depuradores de Clase E/genética , Estrés Psicológico/metabolismo , Animales , Antioxidantes/farmacología , Aorta Torácica/efectos de los fármacos , Aorta Torácica/patología , Apolipoproteínas E/genética , Aterosclerosis/metabolismo , Aterosclerosis/patología , Peso Corporal/fisiología , Corticosterona/sangre , Interpretación Estadística de Datos , Etilenodiaminas/farmacología , Inmunohistoquímica , Ratones , Ratones Noqueados , Óxido Nítrico/metabolismo , Compuestos Organometálicos/farmacología , Estrés Oxidativo/fisiología , Ácido Peroxinitroso/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Restricción Física , Estrés Psicológico/patología , Regulación hacia Arriba/fisiologíaRESUMEN
OBJECTIVES: High-salt diet likely elevates blood pressure (BP), thus increasing the risk of cardiovascular events. We hypothesized that a high-salt diet plays a critical role in subjects whose renin-angiotensin systems cannot adjust to variable salt intake, rendering them more susceptible to atherosclerosis. METHODS: Apolipoprotein E-deficient (ApoE-/-) mice received standard or high-salt diet (8%) alone or in combination with fixed angiotensin II (Ang II) infusion (0.5 microg/kg per min). BP was measured using telemetry, and plaque burden was assessed in the thoracic aorta and innominate artery. We used urinary isoprostane as a marker for oxidative stress. RESULTS: Although high-salt diet per se did not affect plaque extension, high salt combined with Ang II increased plaque area significantly in both the aorta and the innominate artery as compared with Ang II or salt alone (P < 0.05 and P < 0.01, respectively). High-salt diet did not affect BP or isoprostane levels, whereas Ang II infusion increased both BP and isoprostane levels (P < 0.05 and P < 0.01, respectively). Although high-salt diet combined with Ang II did not amplify BP, salt in combination with Ang II increased isoprostane levels further (P < 0.001 vs. Ang II alone). Ang II increases macrophage content in lesions (P < 0.05), whereas salt likely increases collagen content. CONCLUSION: High-salt diet per se does not influence BP in ApoE-/- mice and is only moderately atherogenic. Possibly mediated via increased oxidative stress, a high-salt diet combined with fixed high Ang II levels accelerates atherogenesis synergistically, beyond the effect of BP.
Asunto(s)
Angiotensina II/toxicidad , Apolipoproteínas E/deficiencia , Aterosclerosis/etiología , Cloruro de Sodio Dietético/efectos adversos , Animales , Aorta Torácica/patología , Tronco Braquiocefálico/patología , Femenino , Lípidos/sangre , Ratones , Estrés Oxidativo , Receptor de Angiotensina Tipo 1/análisis , Receptor de Angiotensina Tipo 1/fisiologíaRESUMEN
Social support and a stimulating environment have been suggested to reduce stress reactions and cardiovascular risk. The aim of this study was to assess the role of environmental enrichment and social interaction for development of atherosclerosis in atherosclerosis prone mice. Male ApoE-/- mice were divided into four groups and followed during 20 weeks: (i) enriched environment (E, n=12), (ii) deprived environment (ED, n=12), (iii) enriched environment with exercise (E-Ex, n=12) and (iv) socially deprived by individual housing (SD, n=10). Plasma lipid and cytokine concentrations were measured. Atherosclerosis was quantified in cross-sections of innominate artery and en face in thoracic aorta. Plaque area was significantly increased in SD mice in the innominate artery (P<0.05 vs. all other groups), but not in the thoracic aorta. Plasma lipids were increased in SD mice (P<0.001 vs. all for total cholesterol, P<0.05 vs. E and P<0.01 vs. ED for triglycerides). Plasma concentration of granulocyte-colony stimulating factor (G-CSF) was decreased in SD mice compared to E mice (P<0.05). Thus, social isolation increased atherosclerosis and plasma lipids in ApoE-/- mice. Reduction in plasma G-CSF levels may hamper endothelial regeneration in the atherosclerotic process. While environmental enrichment did not affect atherosclerosis, social isolation accelerated atherosclerosis.
Asunto(s)
Apolipoproteínas E/deficiencia , Aterosclerosis/fisiopatología , Ambiente , Condicionamiento Físico Animal , Aislamiento Social , Animales , Aterosclerosis/etiología , Aterosclerosis/patología , Presión Sanguínea , Corticosterona/orina , Conducta de Ingestión de Líquido , Conducta Exploratoria/fisiología , Factor Estimulante de Colonias de Granulocitos/sangre , Frecuencia Cardíaca , Vivienda para Animales , Lípidos/sangre , Masculino , Ratones , Sodio en la Dieta/administración & dosificaciónRESUMEN
Human growth hormone (GH) excess is linked to increased cardiovascular morbidity and mortality. However, little is known about the effect of GH excess on atherosclerosis. We developed a new mouse model to assess the hypothesis that GH overexpression accelerates atherosclerotic lesion formation. apoE(-/-) mice were crossed with bovine GH (bGH) transgenic mice to yield apoE(-/-) mice overexpressing bGH (apoE(-/-)/bGH). The mice were fed either standard or Western diet. At 22 weeks, atherosclerotic lesion area of thoracic aorta was larger in apoE(-/-)/bGH mice compared with littermate apoE(-/-) mice fed either diet (standard: +161+/-50%, Western: +430+/-134%). Aortic sinus lesions were more severe in apoE(-/-)/bGH mice fed standard diet compared with littermate apoE(-/-) mice. apoE(-/-)/bGH mice had lower (VLDL+LDL)/HDL ratios compared with littermate apoE(-/-) mice, while systolic blood pressure was higher in apoE(-/-)/bGH mice, irrespective of diet. The levels of serum amyloid A and hepatic CRP mRNA were higher in apoE(-/-)/bGH mice than in littermate apoE(-/-) mice. In conclusion, this study shows that excess GH augments the development of atherosclerosis in apoE(-/-) mice. The mechanisms could be direct effects of GH on cellular processes in the vessel wall or the result of concomitant processes such as hypertension or a general inflammatory state.
Asunto(s)
Aorta/patología , Apolipoproteínas E/deficiencia , Aterosclerosis/patología , Dieta , Modelos Animales de Enfermedad , Hormona del Crecimiento/metabolismo , Animales , Apolipoproteínas E/genética , Aterosclerosis/metabolismo , Presión Sanguínea , Proteína C-Reactiva/genética , Proteína C-Reactiva/metabolismo , Cruzamientos Genéticos , Cartilla de ADN , Hormona del Crecimiento/genética , Ratones , Ratones Noqueados , Proteína Amiloide A Sérica/metabolismoRESUMEN
Danshen, in particular its derivative tanshinone IIA (TS), is a promising compound in the treatment of cardiovascular diseases and has been used for many years in traditional Chinese medicine. Although many actions of TS have been researched, its vasodilator effects in pregnancy remain unknown. There have been a few studies that have shown the ability of TS to reduce blood pressure in women with hypertensive pregnancies; however, there are no studies which have examined the vascular effects of TS in the pregnant state in either normal or complicated pregnancies. Our aim was to determine the vasoactive role of TS in multiple arteries during pregnancy including: rat resistance (mesenteric and uterine) and conduit (carotid) arteries. Further, we aimed to assess the ability of TS to improve uterine blood flow in a rodent model of intrauterine growth restriction. Wire myography was used to assess vascular responses to the water-soluble derivative, sodium tanshinone IIA sulphonate (STS) or to the endothelium-dependent vasodilator, methylcholine. At mid-pregnancy, STS caused direct vasodilation of rat resistance (pEC50 mesenteric: 4.47±0.05 and uterine: 3.65±0.10) but not conduit (carotid) arteries. In late pregnancy, human myometrial arteries responded with a similar sensitivity to STS (pEC50 myometrial: 3.26±0.13). STS treatment for the last third of pregnancy in eNOS-/- mice increased uterine artery responses to methylcholine (Emax eNOS-/-: 55.2±9.2% vs. eNOS-/- treated: 75.7±8.9%, p<0.0001). The promising vascular effects, however, did not lead to improved uterine or umbilical blood flow in vivo, nor to improved fetal biometrics; body weight and crown-rump length. Further, STS treatment increased the uterine artery resistance index and decreased offspring body weight in control mice. Further research would be required to determine the safety and efficacy of use of STS in pregnancy.
Asunto(s)
Vasos Sanguíneos/fisiología , Fenantrenos/farmacología , Animales , Velocidad del Flujo Sanguíneo/efectos de los fármacos , Vasos Sanguíneos/efectos de los fármacos , Endotelio Vascular/efectos de los fármacos , Endotelio Vascular/fisiología , Femenino , Humanos , Técnicas In Vitro , Ratones Endogámicos C57BL , Embarazo , Resultado del Embarazo , Ratas Sprague-Dawley , Flujo Sanguíneo Regional/efectos de los fármacos , Arterias Umbilicales/efectos de los fármacos , Arterias Umbilicales/fisiología , Vasodilatación/efectos de los fármacos , Vasodilatadores/farmacologíaRESUMEN
Preeclampsia (PE) and fetal growth restriction (FGR) are serious complications of pregnancy, associated with greatly increased risk of maternal and perinatal morbidity and mortality. These complications are difficult to diagnose and no curative treatments are available. We hypothesized that the metabolomic signature of two models of disease, catechol-O-methyl transferase (COMT(-/-)) and endothelial nitric oxide synthase (Nos3(-/-)) knockout mice, would be significantly different from control C57BL/6J mice. Further, we hypothesised that any differences in COMT(-/-) mice would be resolved following treatment with Sildenafil, a treatment which rescues fetal growth. Targeted, quantitative comparisons of serum metabolic profiles of pregnant Nos3(-/-), COMT(-/-) and C57BL/6J mice were made using a kit from BIOCRATES. Significant differences in 4 metabolites were observed between Nos3(-/-) and C57BL/6J mice (p < 0.05) and in 18 metabolites between C57BL/6J and COMT(-/-) mice (p < 0.05). Following treatment with Sildenafil, only 5 of the 18 previously identified differences in metabolites (p < 0.05) remained in COMT(-/-) mice. Metabolomic profiling of mouse models is possible, producing signatures that are clearly different from control animals. A potential new treatment, Sildenafil, is able to normalize the aberrant metabolomic profile in COMT(-/-) mice; as this treatment moves into clinical trials, this information may assist in assessing possible mechanisms of action.
Asunto(s)
Catecol O-Metiltransferasa/genética , Retardo del Crecimiento Fetal/genética , Retardo del Crecimiento Fetal/metabolismo , Metaboloma/efectos de los fármacos , Preeclampsia/genética , Preeclampsia/metabolismo , Citrato de Sildenafil/farmacología , Animales , Catecol O-Metiltransferasa/metabolismo , Modelos Animales de Enfermedad , Femenino , Retardo del Crecimiento Fetal/tratamiento farmacológico , Metabolómica/métodos , Ratones , Ratones Noqueados , Preeclampsia/tratamiento farmacológico , EmbarazoRESUMEN
Preeclampsia (PE) and fetal growth restriction (FGR) contribute significantly to fetal and maternal morbidity and mortality. Although the causes of PE and FGR are not fully understood, both conditions are known to be associated with impaired uterine artery blood flow. Resveratrol, a polyphenol found in a number of plants, has been shown to induce relaxation of uterine arteries in vitro as well as improve many pathological conditions associated with PE and FGR. We hypothesized that treatment of endothelial nitric oxide synthase knockout mice (eNOSâ»/â») and catechol-O-methyltransferase knockout mice (COMTâ»/â») with resveratrol during pregnancy would improve uterine artery blood flow and therefore ameliorate the PE-like phenotype and FGR in these murine models. Pregnant C57BL/6J, eNOSâ»/â» and COMTâ»/â» mice received either resveratrol supplemented diet (4 g/kg diet) or control diet between gestational day (GD) 0.5 and GD 18.5. Resveratrol supplementation significantly increased uterine artery blood flow velocity and fetal weight in COMTâ»/â» but not in eNOSâ»/â» mice. There were no effects of resveratrol on litter size and placental weight among the groups. In conclusion, resveratrol increased uterine artery blood flow velocity and fetal weight in COMTâ»/â» mice, suggesting potential as a therapeutic strategy for PE and FGR.
Asunto(s)
Retardo del Crecimiento Fetal/tratamiento farmacológico , Preeclampsia/tratamiento farmacológico , Flujo Sanguíneo Regional/fisiología , Estilbenos/farmacología , Útero/irrigación sanguínea , Análisis de Varianza , Animales , Velocidad del Flujo Sanguíneo/efectos de los fármacos , Presión Sanguínea/efectos de los fármacos , Presión Sanguínea/fisiología , Catecol O-Metiltransferasa/genética , Femenino , Peso Fetal/efectos de los fármacos , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Microscopía Acústica , Óxido Nítrico Sintasa de Tipo III/genética , Embarazo , Proteinuria , Flujo Sanguíneo Regional/efectos de los fármacos , Resveratrol , Estilbenos/uso terapéuticoRESUMEN
Preeclampsia and fetal growth restriction are responsible for the majority of maternal and perinatal morbidity and mortality associated with complicated pregnancies. Although their etiologies are complex and multifactorial, both are associated with increased uterine artery resistance. Sildenafil citrate is able to rescue the dysfunction observed ex vivo in uterine arteries of women with preeclampsia. The ability of sildenafil citrate to increase uterine artery vasodilation, thereby decreasing uterine artery resistance and, hence, ameliorated preeclampsia and fetal growth restriction, was tested in a mouse model of preeclampsia, the catechol-O-methyl transferase knockout mouse (COMT(-/-)). COMT(-/-) and C57BL/6J mice were treated (0.2 mg/mL in drinking water, n=6-12) from gestational day 12.5 to 18.5. Measures of pup growth, including body weight, crown/rump length, and abdominal circumference, were reduced in COMT(-/-) mice; this was normalized after treatment with Sildenafil. COMT(-/-) mice also demonstrated abnormal umbilical Doppler waveforms, including reverse arterial blood flow velocity. This was normalized after treatment with Sildenafil. Abnormal uterine artery Doppler waveforms were not demonstrated in COMT(-/-) mice, although ex vivo responses of uterine arteries to phenylephrine were increased; moreover, treatment with Sildenafil did improve ex vivo sensitivity to an endothelium-dependent vasodilator. The data presented here demonstrate that Sildenafil can rescue pup growth and improve abnormal umbilical Doppler waveforms, providing support for a potential new therapeutic strategy targeting fetal growth restriction.
Asunto(s)
Catecol O-Metiltransferasa/metabolismo , Retardo del Crecimiento Fetal/prevención & control , Retardo del Crecimiento Fetal/fisiopatología , Miometrio/irrigación sanguínea , Piperazinas/administración & dosificación , Preeclampsia/tratamiento farmacológico , Sulfonas/administración & dosificación , Arterias Umbilicales/efectos de los fármacos , Animales , Velocidad del Flujo Sanguíneo/efectos de los fármacos , Modelos Animales de Enfermedad , Femenino , Retardo del Crecimiento Fetal/diagnóstico por imagen , Hipertensión/complicaciones , Hipertensión/diagnóstico , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Preeclampsia/fisiopatología , Embarazo , Proteinuria/complicaciones , Proteinuria/diagnóstico , Purinas/administración & dosificación , Citrato de Sildenafil , Ultrasonografía Doppler , Arterias Umbilicales/diagnóstico por imagen , Vasodilatación/efectos de los fármacos , Vasodilatadores/administración & dosificaciónRESUMEN
A low-resistance/high-flow uteroplacental circulation is integral to a healthy pregnancy. Impaired flow in the uterine circulation is associated with intrauterine growth restriction (IUGR) and preeclampsia (PE). Poly(ADP-ribose) polymerase (PARP) is a nuclear enzyme which has been associated with oxidative stress-induced vascular dysfunction. Using the endothelial nitric oxide synthase (eNOS(-/ -)) knockout mouse model, which features vascular dysfunction and IUGR, we tested the hypothesis that administration of a PARP inhibitor may ameliorate the vascular dysfunction associated with the eNOS(-/-) model. eNOS(-/-) animals were characterized by impaired uterine artery function when compared to controls. Administration of the PARP inhibitor PJ34 prevented this dysfunction. Gestational day (GD) 17.5 eNOS(-/-) mice did not exhibit altered systolic blood pressure when compared to control mice. However, treatment of eNOS(-/-) mice with PJ34 significantly reduced systolic blood pressure when compared to vehicle-treated eNOS(-/-). Administration of a PARP inhibitor protects uterine artery function in the face of eNOS(-/-) deficiency.
Asunto(s)
Óxido Nítrico Sintasa de Tipo III/deficiencia , Fenantrenos/farmacología , Inhibidores de Poli(ADP-Ribosa) Polimerasas , Complicaciones del Embarazo/fisiopatología , Arteria Uterina/fisiopatología , Animales , Inhibidores Enzimáticos/farmacología , Femenino , Retardo del Crecimiento Fetal/fisiopatología , Edad Gestacional , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Óxido Nítrico Sintasa de Tipo III/genética , Óxido Nítrico Sintasa de Tipo III/fisiología , Preeclampsia/fisiopatología , Embarazo , Arteria Uterina/efectos de los fármacosRESUMEN
Psychosocial stress is suggested to play a significant role in development of cardiovascular disease. To evaluate the effects of repeated exposure to stress on atherosclerosis in atherosclerosis-prone ApoE(-/-) mice we used five different stressors. We further sought to determine whether stress combined with high salt diet induces dysfunctional neurohormonal regulation and impaired salt excretion, thus amplifying the atherogenic potential of salt. The five stressors were evaluated in male C57BL/6 mice and ApoE(-/-) mice (studies I and II) and then used in female ApoE(-/-) mice to study their effect on atherosclerosis (study III). The mice in study III received standard or high salt diet (8%) alone or in combination with stress for 12 weeks. Urine and plasma were collected for corticosterone and lipid analysis, respectively. Acute blood pressure (BP) and heart rate (HR) responses to stress were measured using telemetry. Plaque burden was assessed in the thoracic aorta and aortic root. Plaque morphology was investigated regarding macrophages and collagen content. Urinary corticosterone chronically increased in stressed mice (P<0.05 control vs. stress, P<0.05 control salt vs. stress salt). BP and HR increased acutely during all stressors (P<0.05). Body weight gain decreased significantly in the stress group (P<0.05 vs. control). However, stress did not alter plasma lipid levels, plaque area or plaque morphology. Increased BP and HR suggest an acute stress-related response in ApoE(-/-) mice. Furthermore, stress chronically decreased body weight gain and increased urinary corticosterone levels. Notably, despite an apparent stress effect, stress affected neither atherogenesis nor plaque morphology.
Asunto(s)
Apolipoproteínas E/deficiencia , Aterosclerosis/psicología , Cloruro de Sodio Dietético/efectos adversos , Estrés Psicológico/complicaciones , Animales , Aorta Torácica/patología , Apolipoproteínas E/genética , Aterosclerosis/genética , Aterosclerosis/patología , Aterosclerosis/fisiopatología , Presión Sanguínea , Peso Corporal , Enfermedad Crónica , Corticosterona/sangre , Corticosterona/orina , Modelos Animales de Enfermedad , Progresión de la Enfermedad , Frecuencia Cardíaca , Lípidos/sangre , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Factores de Riesgo , Estrés Psicológico/fisiopatología , Factores de TiempoRESUMEN
Stress is a risk factor for cardiovascular disease, such as atherosclerosis. Stress during pregnancy (maternal stress) may have long-term consequences for the health of the offspring. However, it is not known whether maternal stress affects the offspring's predisposition to develop atherosclerosis. Atherosclerosis is often related to vascular endothelial dysfunction. We hypothesized that maternal stress affects vascular endothelial function and accelerates development of atherosclerosis in offspring of apolipoprotein E-deficient mice, a model commonly used for atherosclerosis research. Stress was induced by restraining dams in small cylinders for five consecutive days (2 h/day) beginning on gestational day 8 +/- 0.5. Vascular function and development of atherosclerosis in the aorta were determined in male and female offspring at 11-15 wk of age (with early lesions) and at 22-26 wk of age (with established lesions). Endothelium-dependent vasorelaxation was determined using methacholine (0.0001-10 micromol/l) in the absence or presence of the nitric oxide synthase inhibitor N(omega)-nitro-l-arginine methyl ester hydrochloride (l-NAME; 100 micromol/l). Male offspring (11-15 wk old) from stressed dams were less dependent on nitric oxide for relaxation compared with controls (l-NAME inhibition: 38 +/- 10 vs. 69 +/- 6%, P < 0.05). Atherosclerotic lesion area was larger in male and female 25- to 26-wk-old offspring from stressed dams compared with corresponding controls [median (interquartile range): males: 6.8 (5.4-7.7) vs. 5.1 (4.4-5.5), P < 0.05, females: 10.0 (8.9-10.9) vs. 7.0 (4.7-8.7), P < 0.05]. In conclusion, maternal stress renders the apolipoprotein E-deficient offspring more susceptible to develop atherosclerosis.
Asunto(s)
Apolipoproteínas E/deficiencia , Aterosclerosis/genética , Aterosclerosis/fisiopatología , Preñez/fisiología , Preñez/psicología , Estrés Psicológico/genética , Estrés Psicológico/fisiopatología , Animales , Aorta Torácica/patología , Aterosclerosis/psicología , Peso al Nacer , Colesterol/sangre , Corticosterona/sangre , Relación Dosis-Respuesta a Droga , Endotelio Vascular/fisiología , Inhibidores Enzimáticos/farmacología , Femenino , Tamaño de la Camada , Ratones , NG-Nitroarginina Metil Éster/farmacología , Óxido Nítrico/fisiología , Óxido Nítrico Sintasa de Tipo III/antagonistas & inhibidores , Nitroprusiato/farmacología , Tamaño de los Órganos/fisiología , Fenilefrina/farmacología , Embarazo , Estrés Psicológico/psicología , Triglicéridos/sangre , Vasoconstrictores/farmacologíaRESUMEN
The effect of insulin on blood pressure (BP) is debated, and an involvement of an activated renin-angiotensin aldosterone system (RAAS) has been suggested. We studied the effect of chronic insulin infusion on telemetry BP and assessed sympathetic activity and dependence of the RAAS. Female Sprague-Dawley rats received insulin (2 units/day, INS group, n = 12) or insulin combined with losartan (30 mg.kg(-1).day(-1), INS+LOS group, n = 10), the angiotensin II receptor antagonist, for 6 wk. Losartan-treated (LOS group, n = 10) and untreated rats served as controls (n = 11). We used telemetry to measure BP and heart rate (HR), and acute ganglion blockade and air-jet stress to investigate possible control of BP by the sympathetic nervous system. In addition, we used myograph technique to study vascular function ex vivo. The INS and INS+LOS groups developed euglycemic hyperinsulinemia. Insulin did not affect BP but increased HR (27 beats/min on average). Ganglion blockade reduced mean arterial pressure (MAP) similarly in all groups. Air-jet stress did not increase sympathetic reactivity but rather revealed possible blunting of the stress response in hyperinsulinemia. Chronic losartan markedly reduced 24-h-MAP in the INS+LOS group (-38 +/- 1 mmHg P < 0.001) compared with the LOS group (-18 +/- 1 mmHg, P Asunto(s)
Angiotensina II/metabolismo
, Presión Sanguínea
, Ganglios Simpáticos/fisiopatología
, Hiperinsulinismo/fisiopatología
, Hipertensión/fisiopatología
, Sistema Renina-Angiotensina
, Acetilcolina/farmacología
, Bloqueadores del Receptor Tipo 1 de Angiotensina II/farmacología
, Animales
, Antihipertensivos/farmacología
, Antihipertensivos/uso terapéutico
, Aorta/fisiopatología
, Glucemia/metabolismo
, Presión Sanguínea/efectos de los fármacos
, Monitoreo Ambulatorio de la Presión Arterial/métodos
, Modelos Animales de Enfermedad
, Femenino
, Ganglios Simpáticos/efectos de los fármacos
, Bloqueadores Ganglionares/farmacología
, Glucosa/administración & dosificación
, Frecuencia Cardíaca/efectos de los fármacos
, Hexametonio/farmacología
, Hiperinsulinismo/inducido químicamente
, Hiperinsulinismo/complicaciones
, Hiperinsulinismo/tratamiento farmacológico
, Hiperinsulinismo/metabolismo
, Hipertensión/tratamiento farmacológico
, Hipertensión/etiología
, Hipertensión/metabolismo
, Insulina/administración & dosificación
, Sistemas de Infusión de Insulina
, Losartán/farmacología
, Losartán/uso terapéutico
, Miografía
, Ratas
, Ratas Sprague-Dawley
, Renina/sangre
, Sistema Renina-Angiotensina/efectos de los fármacos
, Sistema Renina-Angiotensina/genética
, Telemetría
, Factores de Tiempo
, Vasodilatación
, Vasodilatadores/farmacología
RESUMEN
Acromegaly [overproduction of GH (growth hormone)] is associated with cardiovascular disease. Transgenic mice overexpressing bGH (bovine GH) develop hypertension and hypercholesterolaemia and could be a model for cardiovascular disease in acromegaly. The aims of the present study were to investigate the effects of excess GH on vascular function and to test whether oxidative stress affects endothelial function in bGH transgenic mice. We studied the ACh (acetylcholine)-induced relaxation response in aortic and carotid rings of young (9-11 weeks) and aged (22-24 weeks) female bGH transgenic mice and littermate control mice, without and with the addition of a free radical scavenger {MnTBAP [Mn(III)tetrakis(4-benzoic acid)porphyrin chloride]}. We also measured mRNA levels of eNOS (endothelial nitric oxide synthase) and EC-SOD (extracellular superoxide dismutase). Intracellular superoxide anion production in the vascular wall was estimated using a dihydroethidium probe. Carotid arteries from bGH transgenic mice had an impaired ACh-induced relaxation response (young, 46 +/- 7% compared with 69 +/- 8%; aged, 52 +/- 5% compared with 80 +/- 3%; P < 0.05), whereas endothelial function in aorta was intact in young but impaired in aged bGH transgenic mice. Endothelial dysfunction was corrected by addition of MnTBAP in carotid arteries from young mice and in aortas from aged mice; however, MnTBAP did not correct endothelial dysfunction in carotid arteries from aged bGH transgenic mice. There was no difference in intracellular superoxide anion production between bGH transgenic mice and control mice, whereas mRNA expression of EC-SOD and eNOS was increased in aortas from young bGH transgenic mice compared with control mice (P < 0.05). We interpret these data to suggest that bGH overexpression is associated with a time- and vessel-specific deterioration in endothelial function, initially caused by increased oxidative stress and later by other alterations in vascular function.